Stocksigma LogoStocksigma Logo

Sandu Pharmaceuticals Board Meeting Scheduled for 14th Nov'26 to Approve Q2 Results

Sandu Pharmaceuticals Limited has scheduled a meeting of its Board of Directors on 14th Nov'26 to consider and approve the standalone unaudited financial

Sandu Pharmaceuticals Board Meeting Scheduled for 14th Nov'26 to Approve Q2 Results

Sandu Pharmaceuticals Ltd 路 Intimation 路 14 Nov 2026, 5:30 am

Sandu Pharmaceuticals Board Meeting Scheduled for 14th Nov'26 to Approve Q2 Results Sandu Pharmaceuticals Limited has scheduled a meeting of its Board of Directors on 14th Nov'26 to consider and approve the standalone unaudited financial results for the quarter ended 30th Sep'26. In accordance with SEBI insider trading regulations, the trading window for dealing in company securities has been closed for directors, officers, and designated employees from 1st Oct'26 and will remain shut until 48 hours post the public announcement of the quarterly results.

Original exchange filing (PDF)

More announcements from Sandu Pharmaceuticals Ltd

All Sandu Pharmaceuticals Ltd announcements